Discrepancy Between Neuroimaging Findings and Clinical Phenotype in Alexander Disease

References

1. ↵
   Soffer D, Horoupian DS. Rosenthal fibers formation in the central nervous system: its relation to Alexander’s disease. Acta Neuropathol (Berl)1979;47:81–84

   CrossRefPubMed
2. ↵
   Towfighi J, Young R, Sassani J, et al. Alexander’s disease: further light-, and electron-microscopic observations. Acta Neuropathol (Berl)1983;61:36–42

   CrossRefPubMed
3. ↵
   van der Knaap MS, Valk J. Alexander Disease.In: Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. Berlin, Germany: Springer-Verlag;2005 :416–35
4. ↵
   Spalke G, Mennel HD. Alexander’s disease in an adult: clinicopathologic study of a case and review of the literature. Clin Neuropathol 1982;1:106–12

   PubMed
5. ↵
   van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001;22:541–52

   Abstract/FREE Full Text
6. ↵
   van der Knaap MS, Salomons GS, Li R, et al. Unusual variants of Alexander’s disease. Ann Neurol 2005;57:327–38

   CrossRefPubMedWeb of Science
7. ↵
   Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79

   PubMedWeb of Science
8. ↵
   Klein EA, Anzil AP. Prominent white matter cavitation in an infant with Alexander’s disease. Clin Neuropathol 1994;13:31–38

   PubMedWeb of Science
9. ↵
   van der Knaap MS, Barth PG, Vrensen GF, et al. Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course. Acta Neuropathol (Berl) 1996;92:206–12

   CrossRefPubMed
10. ↵
    Boor PK, de Groot K, Waisfisz Q, et al. MLC1: a novel protein in distal astroglial processes. J Neuropathol Exp Neurol 2005;64:412–19

    PubMedWeb of Science
11. ↵
    Mignot C, Boespflug-Tanguy O, Gelot A, et al. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell Mol Life Sci 2004;61:369–85

    CrossRefPubMedWeb of Science
12. ↵
    Messing A, Goldman JE, Johnson AB, et al. Alexander disease: new insights from genetics. J Neuropathol Exp Neurol 2001;60:563–73

    PubMedWeb of Science
13. ↵
    Li R, Messing A, Goldman JE, et al. GFAP mutations in Alexander disease. Int J Dev Neurosci 2002;20:259–68

    CrossRefPubMedWeb of Science
14. ↵
    Gorospe JR, Naidu S, Johnson AB, et al. Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology 2002;58:1494–500

    Abstract/FREE Full Text
15. ↵
    Rodriguez D, Gauthier F, Bertini E, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet 2001;69:1134–40

    CrossRefPubMedWeb of Science
16. ↵
    Li R, Johnson AB, Salomons G, et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 2005;57:310–26

    CrossRefPubMedWeb of Science
17. Brenner M, Johnson AB, Boespflug-Tanguy O, et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001;27:117–20

    CrossRefPubMedWeb of Science
18. Guthrie SO, Burton EM, Knowles P, et al. Alexander’s disease in a neurologically normal child: a case report. Pediatr Radiol 2003;33:47–49

    PubMed
19. Suzuki Y, Kanazawa N, Takenaka J, et al. A case of infantile Alexander disease with a milder phenotype and a novel GFAP mutation, L90P. Brain Dev 2004;26:206–08

    CrossRefPubMedWeb of Science
20. Shiihara T, Sawaishi Y, Adachi M, K, et al. Asymptomatic hereditary Alexander’s disease caused by a novel mutation in GFAP. J Neurol Sci 2004;225:125–27

    CrossRefPubMedWeb of Science